scispace - formally typeset
D

David Spiegel

Researcher at Stanford University

Publications -  838
Citations -  50967

David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.

Papers
More filters
Journal ArticleDOI

Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients

TL;DR: In this paper, the authors used pilot data from 31 advanced cancer patients who completed once daily the 19-item MD Anderson Symptom Inventory at home, and compared different sampling frequencies for two main outcomes: average symptom intensity and identification of severe symptoms.
Journal ArticleDOI

Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial

TL;DR: While no new safety signals were reported with less frequent, but continual NIVO+IPI dosing in CheckMate 920, the modified regimen was not associated with clinical benefits relative to the approved Nivolumab plus ipilimumab combination dosing schedule for patients with aRCC.
Journal Article

[Nutritional workshops for cancer patients: a pilot approach].

TL;DR: The authors describe an original experience with 3 years of a nutritional workshop for cancer patients, which combine an information about nutritional aspects of cancer with psychosocial support, to buffer psychological and nutritional consequences of cancer.
Journal ArticleDOI

Pentosinane, a Post-Translational Modification of Human Proteins with Underappreciated Stability.

TL;DR: In this article , the first total synthesis of pentosinane was reported, which is based on the 2,5-diaminoimidazoles previously developed by the same authors.